secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001601485-24-000006
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio raises ~$4.9M from ATM equity sales since Q3 2023
--------------------------------------------------------

- Issued and sold 584,170 shares under at-the-market program since September 30, 2023.
- Net proceeds of approximately $4.89 million after deducting sales commissions.
- Original ATM program authorized up to $21.0 million in aggregate offering price.
- Program is ongoing with Stifel and Virtu Americas LLC as agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000006/0001601485-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000006/angn-20240116.htm
  HTML page:      https://secwatch.observer/filing/0001601485-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer